Introduction
Osteosarcoma is a more common primary malignant bone tumor accounting for 15% of the primary bone tumors, and the incidence rate is about 0.3 per million. It often occurs in adolescents [1] and is characterized by high morbidity and mortality [1, 2] . Clinical manifestations of the disease include limb pain, lumps, limping, and pathologic fractures. Some patients suffer from fever, anemia, and weight loss; distant metastasis can occur, causing serious injury for adolescent health [3, 4] .
The main pathogenic sites of osteosarcoma are the tubular bones of the extremities [5, 6] ; the upper tibia is the osteosarcoma predilection site [7] . In recent years, surgery is given priority in the treatment of osteosarcoma, which significantly increased the survival rate of patients [8] . The traditional surgical approaches include amputations, massive osteoarticular allografts, and tumor resection and artificial joint replacement.
From August 2006 to October 2012, 112 patients with proximal upper tibia osteosarcoma were treated at our hospitals with 3 surgical techniques including amputation, massive osteoarticular allograft, and tumor resection and artificial joint replacement. The aim of our study was to retrospectively assess the clinical effects of these 3 surgical techniques for the treatment of upper tibia osteosarcoma.
Patients and Methods

Patients
The study was approved by the ethics committee of the Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, and written informed consent was obtained from all subjects. We retrospectively collected the clinical data of patients with proximal upper tibia osteosarcoma treated at our hospital between August 2006 and October 2012. The inclusion criteria were: (1) patients whose clinical manifestation, imaging and
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Summary
Background:
We aimed to explore the clinical effects and prognosis of different surgical methods in upper tibia osteosarcoma. Methods: Among 112 patients with proximal upper tibia osteosarcoma, 40 patients were treated with amputation, 20 patients were treated with massive osteoarticular allograft, and the remaining 52 cases were treated with tumor resection and artificial joint replacement. Results: Recurrence was observed in 2 cases (5%) in the amputation group, in 6 cases (30%) in the massive osteoarticular allograft group, and in 6 cases (12%) in the tumor resection and artificial joint replacement group (P = 0.021). The lung metastasis rates were 40% in the amputation group, 40% in the massive osteoarticular allograft group, and 38% in the tumor resection and artificial joint replacement group (P = 0.986). The survival rates at 1, 3, and 5 years were 95%, 75%, and 45%, respectively, in the amputation group, 95%, 75%, and 35%, respectively, in the massive osteoarticular allograft group, and 92.3%, 78.8%, and 53.8%, respectively, in the tumor resection and artificial joint replacement group (P > 0.05). Conclusions: The selection of the optimal surgical method for upper tibia osteosarcoma should be made according to the individual circumstances of the patient. Our study has significance for reducing the incidence of surgical complications and improving the quality of postoperative life.
Outcomes and Prognosis of Treatment of Upper Tibia Osteosarcoma
Oncol Res Treat 2017;40:528-532 529 pathological results met the criteria of osteosarcoma; (2) patients were staged according to the Enneking staging system and one of the 3 surgical methods was chosen based on the indications; (3) the osteosarcoma was located in the upper tibia; and (4) all patients had postoperative routine chemotherapy and other comprehensive treatment. The exclusion criteria were: (1) patients had insufficient data or were lost to follow-up; (2) patients with organ failure such as heart and lung failure; and (3) patients with distant metastases.
Surgical Technique Preoperative Preparation
The clinical manifestation results combined with the files of X-ray scans, computed tomography (CT), magnetic resonance imaging (MRI), and singlephoton emission CT (SPECT) were used thoroughly to determine the degree of tumor invasion in the bone and soft tissue. Attention should be paid to knowledge on the degree of neurovascular involvement and the knee joint status. Then, distant metastasis of the tumor should be excluded; thereafter, the Enneking stage should be determined and optimized surgical methods should be selected. All patients received neoadjuvant chemotherapy before surgery, including epirubicin, cisplatin, high-dose methotrexate, vincristine, and ifosfamide [9] .
For limb salvage patients, total knee replacement prostheses or a long segment of allogeneic bone and an interlocking intramedullary nail system should be prepared before operation [10] . For the treatment of the included cases, we made a comprehensive assessment of the patient's condition and then formulated an effective therapeutic plan based on treatment guidelines and rules. All surgeons were from the same team. The selection of the operation method and the resection range of the tumors were formulated on account of preoperative imaging examinations and shared counseling.
Surgical Methods
Amputation
The amputation level was determined according to the preoperative imaging data. The great saphenous vein was ligatured and separated on the limb plane. The femoral artery and vein and the saphenous nerve were separated from the sartorius muscle or the adductor canal, and were cut off by conventional processing. The deep femoral artery and the deep femoral vein were separated from the femur section, the adductor magnus, and the biceps femoris muscle. Thereafter, double ligation was conducted. The sciatic nerve was slightly separated from the semitendinosus, semimembranous muscle and the biceps femoris muscle. Circular amputation of the muscle was performed 2-3 cm below the amputation level until the femur; the muscle was then cut off after ligation of the nutritional vessels. On the predetermined truncation plane, the periosteum was stripped, followed by detachment of the femur and dividing of the affected limb.
Massive Osteoarticular Allograft An anteromedial incision was made between the terminal femur and the upper tibia. The biopsy channel underwent fusiform excision. Neurovascular bundles were exposed and protected. The affected tibia was stripped outside the tumor boundary.
Upper tibia resection for tumors was conducted at a distance of 3-5 cm to the tumor. The capitulum fibulae was removed. The knee allograft was repaired during the operation. The allograft attachments of the ligamentous structures were reserved. They were replanted back on the host interface with the bone cement fixation technique, and the continuity of bone and joint was recovered. The medial head of the gastrocnemius muscle was transferred to repair softtissue defects at the crus inside.
Tumor Resection and Artificial Joint Replacement Rotating hinge-type plug-in tibia prosthesis was determined according to preoperative MRI of the limb. The adequate size of the rotating-hinge tibial prosthesis was prepared. According to the location of the tumor involvement, the surgical approach was selected as either anteromedial or anterolateral of the knee joint. Osteotomy was made 3 cm inferior to the lesion of the tibia. After appropriate installation of the prosthesis with no looseness, the articular and stretching knee was reconstructed. The tibial medullary cavity was expanded. Then, the tibial prosthesis was tested. The medial gastrocnemius flap transfer was performed to cover the prosthesis when needed. A suction drainage tube was placed [11] .
Postoperative Management
Cefathiamidine was used at 30 min before the operation, to prevent infection. Cefoperazone and tazobactam were used for 1-3 weeks after the operation, to prevent infection. Anticoagulant therapy was conducted to prevent deep vein thrombosis 24 h after the operation. Blood routine and biochemical test results had to be checked at 6 h and 1 day after the operation, respectively. The lower limb should not bear weight and should be supported by orthoses. Isometric exercise was taken up within 1 week post operation, and isotonic exercise was taken up 2 weeks after surgery. Pain medications were given if necessary. According to the recovery condition of the affected limb, moderate weights were applied.
Clinical Evaluation and Follow-Up
The X-ray radiographs were taken every month in the first 3 months, and thereafter every 3 months after surgery. During the follow-up, functional Musculoskeletal Tumor Society (MSTS) scores at 6 months post operation, the local recurrence rate, the lung metastasis rate, and the 1-, 3-and 5-year survival rates of the upper tibia osteosarcoma patients were evaluated.
Statistical Analysis
All analyses were performed using SPSS 20.0 software (SPSS, Chicago, IL, USA). Qualitative data were expressed as frequency and percentage. The Χ 2 test was used to examine the relation between qualitative variables. Quantitative data are presented as means ± standard deviation (SD) and were compared using one-way analysis of variance (ANOVA). Survival probabilities were constructed using Kaplan-Meier survival estimates and compared using the log-rank test. Differences were considered statistically significant when P < 0.05.
Results
Baseline Data
A total of 112 patients with proximal upper tibia osteosarcoma were included in this study. There were 64 male and 48 female patients with a mean age of 19.4 years (range 11-46). The patients were divided into 3 groups according to the surgical modalities: amputation group (n = 40); massive osteoarticular allograft group (n = 20); tumor resection and artificial joint replacement group (n = 52). There were no statistically significant differences with regard to age, sex, tumor location, Enneking staging, and tumor size among the 3 groups (all P > 0.05) (table 1).
Function Outcomes
The MSTS scores at 6 months post operation were 10.60 ± 1.65 (7) (8) (9) (10) (11) (12) (13) in the amputation group, 22.45 ± 1.82 (19) (20) (21) (22) (23) (24) (25) (26) in the massive osteoarticular allograft group, and 25.23 ± 1.17 (22) (23) (24) (25) (26) (27) in the tumor resection and artificial joint replacement group (table 2) .
There were significant differences regarding the 6-month postoperative MSTS scores among the 3 groups (P = 0.000).
Recurrence Rate
Recurrence was observed in 2 cases (5%) in the amputation group, in 6 cases (30%) in the massive osteoarticular allograft group, and in 6 cases (12%) in the tumor resection and artificial joint replacement group (P = 0.021) (table 2). The amputation group had a lower local recurrence rate compared to those of the massive osteoarticular allograft group and the tumor resection and artificial joint replacement group (P = 0.007 and 0.000, respectively). No significant differences regarding the local recurrence rate were noted between the massive osteoarticular allograft group and the tumor resection and artificial joint replacement group (P = 0.06).
Lung Metastasis Rate
Lung metastasis can be seen in 16 cases (40%) in the amputation group, in 8 cases (40%) in the massive osteoarticular allograft group, and in 20 cases (38%) in the tumor resection and artificial joint replacement group (table 2) . No significant differences regarding the lung metastasis rates were observed among the 3 groups (P = 0.986).
Long-Term Survival Rate
The survival rate at 1, 3, and 5 years was 95%, 75%, and 45%, respectively, in the amputation group, 95%, 75%, and 35%, respectively, in the massive osteoarticular allograft group, and 92.3%, 78.8%, and 53.8%, respectively, in the tumor resection and artificial joint replacement group. No significant differences regarding the long-term survival rates were observed among the 3 groups (P = 0.242) ( fig. 1 ).
Discussion
Surgery remains the main treatment of osteosarcoma. The primary principle of the surgery has been the full removal of the lesion together with the achievement of a good resection margin [12] . A wide surgical margin would significantly reduce the recurrence rate. The ideal surgical outcome is to achieve a normal organizational boundary around the pseudocapsule of lesions with a margin larger than 1 cm margin outside the reaction zone. During surgery, the pseudocapsule and the tumor should not be exposed. With the development of neoadjuvant chemotherapy and surgical techniques, the therapeutic effect on osteosarcoma has been sig- nificantly improved [13] . Currently, limb salvage surgery has been established as an alternative to amputation [14] [15] [16] [17] . During limb salvage surgery, the combined use of chemotherapy could improve the prognosis of limb salvage. Patients with phase IIb disease or below are considered to be within the current internationally recognized standard for the treatment of osteosarcoma by limb salvage surgery. Each surgical method has different advantages and disadvantages. Amputation is a devastating surgery, although it has the advantages of complete tumor resection and low local recurrence rates; however, it can result in physiological dysfunction of the body and a series of psychological problems. The massive osteoarticular allograft has the advantages of a wide variety of sources and convenient use; it could restore continuity and the volume of the bone, reconstruct the joint structure and provide the attachment of soft tissue. The disadvantages include immunological rejection, the inability to bear weight for a long time, and late functional recovery. The major complications include deep infection, bone resorption, bone nonunion, fractures, articular step-off, internal fixation loosening or rupture, advanced joint degeneration and step-off, and joint instability. The tumor segment resection and artificial joint replacement has the advantage of completely removing the focal lesions. It could reduce the pain of the patient and help to improve the joint stability. Most patients with primary osteosarcoma are relatively young. These patients have many daily activities and duties and high functional requirements, which lead to higher requirement for prosthesis design, material properties, and technical fixtures. The principle of tumor surgery requires extensive soft-tissue resection, which inevitably changes the force and balance mechanism of joint and prosthesis and reduces the stability of the prosthesis. In clinical practice, the individual tumor prosthesis should be made according to the individual variations of the tumor patients.
Recurrence and metastasis of the osteosarcoma usually occur at 1-3 years after surgery [18] . In this study, we compared the local recurrence rates and long-term survival rates after application of the 3 surgical methods, and we found that all 3 of these surgical modalities had a certain recurrence and lung metastasis rate. Chemotherapy could reduce the recurrence rate and the lung metastasis rate of osteosarcoma, which has become an important factor that could improve the survival rates after limb salvage surgery [19] . In this study, the operative range and the osteotomy are based on imaging results, such as MRI/CT scans. In order to avoid the possible effects of surgical distance on recurrence, we conducted resection at a distance of 3-5 cm to the tumor, thus obtaining the security boundary.
Massive osteoarticular allograft and tumor resection plus artificial joint replacement are more beneficial in protecting the limb function, enabling the patients' daily life and improving their selfconfidence. However, attention should be paid to the postoperative complications [20] . The main complications include infection, fracture, nonunion, loosening, and so on. Amputation does not have the above complications, so it still has some value in the treatment of osteosarcoma [21] .
Due to the lack of skin, muscle, and other soft tissue around the tibia, extensive tumor resection will inevitably cause skin defects of the anterior tibia. Even though the skin and some subcutaneous tissue can be retained, the skin directly covering the prosthesis will cause poor local blood supply, wound infections, skin necrosis, splitting, sinus formation, or even implant exposure. In addition, adhesion of the scarred skin to the prosthesis may easily cause secondary injury, infection, and anchylosis, which may eventually lead to failure of the surgery. Malawer and Mchale [22] first utilized a transferred medial gastrocnemius muscle for the resection of a large segment of the tibia and the knee joint and reconstruction of the patellar/extensor mechanism. Long-term follow-up observation showed that the medial gastrocnemius transfer could significantly reduce wound complications, enhanced the knee stability, reduced loosening and rupture and improved knee extension [23] . The medial gastrocnemius muscle flap has the following clinical anatomic characteristics: (1) It has a relatively complete and independent blood circulatory system. (2) It is closer to the middle and upper segment of the tibia prosthesis or the exposed areas of the allograft bone compared to the lateral gastrocnemius muscle flap, which reduces the consumption of the pedicle length and the area of the myocutaneous flap, thus providing sufficient blood for the whole myocutaneous flap and ensuring easier and Fig. 1 . Kaplan-Meyer analysis of postoperative survival in the amputation group, the massive osteoarticular allograft group, and the tumor resection and artificial joint replacement group. The survival rate at 1, 3, and 5 years was 95%, 75%, and 45%, respectively, in the amputation group, 95%, 75%, and 35%, respectively, in the massive osteoarticular allograft group, and 92.3%, 78.8%, and 53.8%, respectively, in the tumor resection and artificial joint replacement group. safer myocutaneous flap transfer. (3) It does not require anastomosing of blood vessels due to its reliable blood supply, which guarantees myocutaneous flap survival. Weinberg et al. [24] reported the outcomes of the myocutaneous flap for large malignant tumors of the knee or adjacent to the knee. After a minimum of 3 years to a maximum of 7 years of follow-up, they concluded that myocutaneous flap transfer was proven to be a valuable adjunct in limb-sparing surgery.
The postoperative follow-up of our study showed that transposition of the medial gastrocnemius head is an ideal method for the reconstruction of soft-tissue defects after resection of proximal tibia bone tumors. The transposition of the medial gastrocnemius head fills the dead space in the upper segment of the tibia, increases the local blood supply and effectively decreases local complications. The muscle flap fascia sutures with joint soft tissue and patellar tendon could enhance the knee joint stability, improve the limb function and increase the lifetime of the prosthesis, and increases the efficiency of local anti-infection treatment. Due to the translocation of the medial gastrocnemius head, the prosthesis and the allograft bone are covered, which may help prevent delayed wound healing and thus increases the patients' survival rates. Whether wound healing disturbances can be reduced by a gastrocnemius flap, thus increasing the survival rates, is our future research direction.
Conclusions
The selection of optimal surgical methods for upper tibia osteosarcoma should be made according to the individual circumstances of the patients. The 3 surgical approaches have no effect on the postoperative metastasis rate and the long-term survival rate. This has a very important significance for reducing the incidence of surgical complications and improving the quality of surgery and of postoperative life.
